Home›Companies›Biotech & Pharma›Pheiron

Pheiron, Inc.

Pheiron builds drug development prediction models for scientists and investors.

Updated Nov 17, 2026·Latest SEC filing Jun 20, 2025·Suggest an edit

About Pheiron

Pheiron is a private company based in Wilmington, Delaware, incorporated in 2023 in Delaware. It has reported $4,224,996 raised in one offering on Form D since June 2025. Its chief executive is Thore Buergel.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 6, 2025Jun 20, 2025$4,224,996of $7.0M target12$352KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Pheiron's Form D filed Jun 20, 2025.

TB
Thore Buergel
Chief Executive Officer and director
JS
Jakob Steinfeldt
Executive officer and director

Sources

  1. SECPheiron, Inc. filing history
  2. CompanyAbout Pheiron